Recurrent aburtion. Spontaneous abortion
Conditions
Interventions
IVIG 400 mg per kg of body weight once every four weeks until week 32 of pregnancy.
Treatment - Drugs
IVIG 400 mg per kg of body weight once every four weeks until week 32 of pregnancy
Sponsors
Tabriz university of medica; sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 41 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients who experienced at least three miscarriage; patients with Azeri origin; Patients who did not have any type of immunotherapy in his medical history. Exclusion criteria: Patients below 18 years and above 41 years; Patients with abnormal karyotype or chromosomal disorders; patients who have bleeding problems; Patients who have chronic disorders such as diabetes; Patients who have HIV, HCV or HBV positive tests; Patients who have a history of asthma and allergies to certain drugs; patients who have uterus anomalies.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pregnancy rate. Timepoint: After treatment. Method of measurement: Live birth. | — |
Secondary
| Measure | Time frame |
|---|---|
| Immune cells modification. Timepoint: After treatment. Method of measurement: Flow cytometry, ELISA, RT-PCR. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Yousefi
Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Outcome results
None listed